Literature DB >> 7183646

Girdlestone arthroplasty.

S Sharma, L Gopalakrishnan, S S Yadav.   

Abstract

A series of 92 patient who underwent excision arthroplasty of the hip (Girdlestone arthroplasty) as a primary procedure is presented. The operation was performed for various conditions which included femoral neck fracture, rheumatoid arthritis, ankylosing spondylitis, tuberculosis, septic arthritis, unreduced posterior dislocation of long duration, fracture of the acetabulum, avascular necrosis of femoral head and bony ankylosis. Excision of head and neck of the femur was found to be an excellent salvage procedure for infected hips especially yielding uniformly satisfactory results at all ages irrespective of the disease. It provided a painless, mobile hip. Except for shortening and unstable gait, no other handicap was observed; the disadvantages of this handicap were outweighed by its advantages, compared with the disadvantages of other sophisticated hip operations such as replacement, and mould arthroplasties or even total hip replacement. Our results were excellent in 21% of cases, good in 44% and fair in 26% while they were poor in 9%. In view of its functional end results, we feel that this measure can be a good alternative to more modern and sophisticated hip operations in the form of partial or total hip replacement under Indian conditions.

Entities:  

Mesh:

Year:  1982        PMID: 7183646

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

1.  Atraumatic posterior dislocation of the native hip: an unusual presentation of septic arthritis.

Authors:  N K Patel; J Windley; S Naique
Journal:  Musculoskelet Surg       Date:  2012-06-09

2.  Long-term results of the Girdlestone hip.

Authors:  R T Müller; K F Schlegel; H Konermann
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

3.  Tuberculous coxitis: diagnostic problems and varieties of treatment: a case report.

Authors:  H Klein; Jb Seeger; I Schleicher
Journal:  Open Orthop J       Date:  2012-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.